Operationalising antimicrobial resistance surveillance data in conflict areas - 24/04/25
Doi : 10.1016/S1473-3099(25)00227-0
Viktoria V Potochilova a, b, Scott J C Pallett c 
, Luke S P Moore c, d, Matthew K O’Shea e, Olena V Moshynets b
, Luke S P Moore c, d, Matthew K O’Shea e, Olena V Moshynets b a Kyiv City Maternity Hospital No 2, Kyiv, Ukraine
b Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, Kyiv, Ukraine
c Clinical Infection Department, Chelsea and Westminster Hospitals NHS Foundation Trust, London SW10 9NH, UK
d National Institute for Health Research Health Biomedical Research Centre, Imperial College London, London, UK
e Institute of Immunology and Immunotherapy, College of Medical & Dental Sciences, University of Birmingham, Birmingham, UK
Il testo completo di questo articolo è disponibile in PDF.
© 2025
Elsevier Ltd. Tutti i diritti riservati.
Vol 25 - N° 5
P. e259 - maggio 2025 Ritorno al numero
Articolo precedente
- Missed opportunities for equity: a crucial perspective on the Lancet’s Zika virus research Series
- Bethânia de Araújo Almeida, Enny S Paixão, Mariana Lima Pitta, Mauricio L Barreto, Laura C Rodrigues, LIFE Zika Study group
- DR Congo’s conflict and cholera: a call for ring vaccination
- Abdullah A Al-Rabeeah, Shahul H Ebrahim, Dieudonné Mwamba, John Ditekemena, Christos Christou, Sania Nishtar, Ziad A Memish
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?